<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02410304</url>
  </required_header>
  <id_info>
    <org_study_id>BCD RB 14.097</org_study_id>
    <nct_id>NCT02410304</nct_id>
  </id_info>
  <brief_title>Pragmatic Study Comparing the Clinical Evlauation Methods ( C) and / or Ultrasound Method ( B or D) in Rheumatoid Arthritis to Adapt Treatment</brief_title>
  <acronym>BCD</acronym>
  <official_title>Pragmatic Study Comparing the Clinical Evlauation Methods ( C) and / or Ultrasound Method ( B or D) in Rheumatoid Arthritis (RA) to Adapt Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares different methods of clinical evaluation (C) and/or ultrasound (B or D)
      concerning the rheumatoid arthritis in order to monitore the treatment. This study will
      provide the exact number of patients in remission according the 3 methods.

      It could allow to assess the concordance between the 3 evaluated methods. This study will
      permit to define the best method which limit the evolution of structural damages ( principal
      criteria).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of this study is to evaluate the Xrays evolution at 1 year ( at least one new erosion
      versus no erosion with the Sharp modified by van der Heijde) of patients affected by
      rheumatoid arthritis (ACR/EULAR 2010). The first approach is the assessment of remission
      defined by modified SDAI in order to evaluate in all cases the same number of joints
      [Simplified Disease Activity Index algebric sum of 5 parametres : number of painful joints
      (28 joints) , number of synovitis (38 joints), global evaluation of patient and and
      practitioner with VAS, and PCR ≤ 3.3mg/l] (mode C). The second one is a combined approach:
      clinical-ultrasound (same criteria but with MTPs and shoulders in B mode so a 26 joints
      evaluation with clinical examination and 12 joints evaluation in B mode) (mode B). The last
      one is an ultrasound approach (remission defined as the absence of power Doppler on 38 joints
      (28 of SDAI plus 10 MTPs joints) (mode D) in a pragmatical context (study assessed by private
      rheumatologists and hospital rheumatologists).

      This trial is a National randomized multicentre trial that compares three modes of follow to
      adjust the therapeutic adaptation in Rheumatoid Artritis.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 6, 2015</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessement of the Xrays evolution at 1 year through adaptated treatment according to clinical or ultrasound remission criteria.</measure>
    <time_frame>1 year</time_frame>
    <description>The primary outcome is to evaluate the Xrays evolution at 1 year ( at least one new erosion versus no erosion with the Sharp modified by van der Heijde) of rheumatoid arthritis patients (ACR/EULAR 2010) according to remission defined by modified SDAI in order to evaluate in all cases the same number of joints [Simplified Disease Activity Index algebric sum of 5 parametres : number of painful joints (28 joints) , number of synovitis (38 joints), global evaluation of patient and practitioner with VAS, and PCR ≤ 3.3mg/l] (mode C), with a combined approach clinical-ultrasound (same criteria but with MTPs and shoulders in B mode so a 26 joints evaluation with clinical examination and 12 joints evaluation in B mode) (mode B) or an ultrasound approach (remission défined as the absence of power Doppler on 38 joints (28 of SDAI plus 10 MTPs joints) (mode D) in a pragmatical context (study assessed by private rheumatologists and hospital rheumatologists).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluation of the proportion of rheumatoid arthristis in remission according to the method used</measure>
    <time_frame>at 3 month, 6 month, 9 month and 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessement of the Xrays evolution at 2 years</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">561</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <arm_group>
    <arm_group_label>Arm C (Clinical)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>No drug and no placebo were used in this arm. Patients were followed only by clinical évaluation.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm B (Clinical + Ultrasound)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>No drug and no placebo were used in this arm. Patients were followed by Clinical evaluation in combination with ultrasound (in B mode).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm D (Ultrasound)</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>No drug and no placebo were used in this arm. Patients were followed by Ultrasound approach in D mode.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Xrays</intervention_name>
    <description>Clinical evaluation</description>
    <arm_group_label>Arm C (Clinical)</arm_group_label>
    <arm_group_label>Arm B (Clinical + Ultrasound)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound (B mode )</intervention_name>
    <arm_group_label>Arm B (Clinical + Ultrasound)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound (D mode)</intervention_name>
    <arm_group_label>Arm D (Ultrasound)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  Inclusion Criteria:

               -  Both gender patients aged 18 -to 80 years old

               -  Patients will be eligible if they fulfill ACR/EULAR 2010 rheumatoid arthritis

               -  All the treatment recommended for rheumatoïd arthritis (anti-inflammatory drugs,
                  steroids, hydroxychloroquine, salazopyrine, methotrexate, ARAVA or biologics
                  treatment: Enbrel, humira, remicade, cimzia, tocilizumab, rituximab, abatacept,
                  simponi) would be in stable posology since at least 12 weeks before inclusion

               -  Patients would be able to understand and be agree with the protocole

               -  Patients would be able to consent

          -  Exclusion Criteria:

               -  Patient unable to cooperate patient and who refuse to sign consent form

               -  Patient unable to understand the study,under administrative supervision or legal
                  guardianship

               -  Signs and symptoms of uncontroled or severe progressive pathology at the level of
                  renal, hepatic, hematological, endocrine, lung, cardiac, neurological or cerebral

               -  Scheduled surgery procedure during the study on the estimated joint.

               -  Patient non-affiliated to social security

               -  Pregnant and nursing mothers
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sandrine Jousse-Joulin, Dr</last_name>
    <phone>+33298347267</phone>
    <email>sandrine.jousse-joulin@chu-brest.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <zip>49100</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Hoppé, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Emmanuel Hoppé, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHRU Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandrine Jousse-Joulin, Dr</last_name>
      <phone>33298347267</phone>
      <email>sandrine.jousse-joulin@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>Sandrine Jousse-Joulin, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU La Roche sur Yon</name>
      <address>
        <city>La Roche sur Yon</city>
        <zip>85925</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Grégoire Cormier, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Grégoire Cormier, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Le Mans</name>
      <address>
        <city>Le Mans</city>
        <zip>72037</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuel Dernis, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Emmanuel Dernis, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Lorient</name>
      <address>
        <city>Lorient</city>
        <zip>56322</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>José Le Noach, Dr</last_name>
    </contact>
    <investigator>
      <last_name>José Le Noach, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Nantes</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Benoît Le Goff, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Benoît Le Goff, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHR Orléans</name>
      <address>
        <city>Orléans</city>
        <zip>45067</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carine Salliot, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Carine Salliot, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU SUD Rennes</name>
      <address>
        <city>Rennes</city>
        <zip>35203</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aleth Perdriger, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Aleth Perdriger, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU Tours</name>
      <address>
        <city>Tours</city>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Saloua MRAGHNI, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Saloua MRAGHNI, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Vannes</name>
      <address>
        <city>Vannes</city>
        <zip>56017</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sylvie Hoang, Dr</last_name>
    </contact>
    <investigator>
      <last_name>Sylvie Hoang, Dr</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 2, 2015</study_first_submitted>
  <study_first_submitted_qc>April 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2015</study_first_posted>
  <last_update_submitted>October 11, 2017</last_update_submitted>
  <last_update_submitted_qc>October 11, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Rheumatoid arthritis / ultrasonography / synovitis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

